
Genprex (Nasdaq: $GNPX) is a clinical-stage gene therapy company focused on developing life-changing technologies for patients with cancer and diabetes.
Austin, TX
Joined July 2016
- Tweets1.3K
- Following501
- Followers2.4K
- Likes260
Genprex Presents Preclinical Data Identifying TROP2 as a Potential Predictive Biomarker for Reqorsa® Gene Therapy in Lung Cancer: genprex.com/2026/11/19/genpr… #Biomarkers #LungCancer
Watch our new video, "Dual Delivery Strategies for Diabetes Gene Therapy," where $GNPX Senior Director of Quality Control & Product Development, Pier-Anne Lachance, Ph.D presents lessons from parallel AAV and lipid-based development programs: genprex.com/videos/#Diabetes #GeneTherapy
Genprex to Highlight Dual Delivery Strategy for Diabetes Gene Therapy at Future of Cell and Gene Therapy Symposium: ow.ly/4KvK5105MGl #GeneTherapy #Diabetes
Genprex executives are in Cologne at #BioEurope, connecting with biotech leaders, sharing updates on our programs and exploring opportunities to build new partnerships or collaborations.
Genprex Presents Data Showing Reqorsa® Gene Therapy Activates Cellular Repair and Maintenance Programs Linked to Aging Biology in Patients, Supporting TUSC2 as a Key Regulator of Resilience to Aging-Associated Stress: genprex.com/2026/11/05/genpr… $GNPX
Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa® Gene Therapy in Lung Cancer: genprex.com/2026/11/04/genpr… #LungCancer $GNPX
2
146
$GNPX CEO recently sat down with the Beyond Biotech Podcast to highlight our diabetes gene therapy and its potential within the therapeutic landscape. Learn more about how we're aiming to address the unmet medical needs of #diabeticpatients
Listen here: ow.ly/Yf5m51034J9
172
Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging: ow.ly/KBsY50ZZGQ3 #Aging
3
519
Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference: ow.ly/iM7q50ZKCLi #GeneTherapy #LungCancer #Diabetes
1
4
229
$GNPX has treated 100+ patients with Reqorsa® throughout its various clinical trials. While other cancer treatments can cause harsh side effects and have long-term effects, we believe in REQORSA’s high degree of patient safety and tolerability #LungCancer
1
4
283
Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy: ow.ly/X8cq50ZATey #Diabetes #GeneTherapy
4
302
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies: ow.ly/YY5m50ZvMn7 #LungCancer
Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer: ow.ly/9Bj150ZfcY9 #LungCancer #GeneTherapy
Genprex to Participate at BIO International Convention 2026: ow.ly/WLjg50ZcIk6 #BIO2026 #GeneTherapy #LungCancer #Diabetes
1
114
A few members from the Genprex team attended #ASCO2026 this week where our collaborators' abstract was published detailing positive clinical data from studies of predictive biomarkers in patients receiving Reqorsa® for the treatment of #lungcancer.
3
225
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting: ow.ly/mlEW50Z4bQs #ASCO #LungCancer
4
176
Our research collaborators presented positive preclinical data on our diabetes gene therapy at the 2026 ASGCT Annual Meeting. The poster can be reviewed in detail by clicking here: ow.ly/5to850Z0ee2 #Diabetes #Type2 #GeneTherapy
4
168
Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting: ow.ly/uQlx50YZtGn #GeneTherapy #Diabetes
3
224
Genprex was featured in Cure's Member Spotlight series, where they highlight the groundbreaking work of the companies and individuals in Cure’s community. Check out the Q&A with Genprex's President and CEO here: ow.ly/ByIR50YZ0Ns #GeneTherapy #LungCancer #Diabetes
Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer: ow.ly/irx250YSoy9 #GeneTherapy #LungCancer
















